Literature DB >> 24257659

Relationship of plasma metal ions and clinical and imaging findings in patients with ASR XL metal-on-metal total hip replacements.

Eric Y Chang1, James L McAnally, James R Van Horne, James G Van Horne, Tanya Wolfson, Anthony Gamst, Christine B Chung.   

Abstract

BACKGROUND: Plasma metal ion levels are commonly used in the postoperative follow-up evaluation of patients who have had a metal-on-metal hip arthroplasty. However, the relationship between these levels and clinical and imaging findings is not well known.
METHODS: We evaluated 156 consecutive patients who received a unilateral ASR XL total hip replacement. Patients presented, regardless of symptoms, in response to a voluntary recall of the hip replacement by the manufacturer and were assessed with regard to the presence and type of symptoms and plasma cobalt-chromium levels. In addition, radiographic and magnetic resonance imaging studies were performed and analyzed.
RESULTS: Eighty patients were asymptomatic, and seventy-six patients were symptomatic. The median cobalt level was 1.8 ppb, and the median chromium level was 1.0 ppb (at or below measurement threshold). Pseudotumors that could be detected on magnetic resonance imaging were seen in 69% (107) of 156 patients, and radiographic osteolysis was evident in 7% (eleven patients). At a threshold of 5 ppb, no association was detected between abnormal metal ion levels and patient symptoms, prosthetic femoral head size, or acetabular cup inclination. An abnormal cobalt level was significantly associated with the presence of periprosthetic lucency on radiographs and pseudotumor on magnetic resonance imaging (p < 0.05). An abnormal chromium level showed a similar pattern, but the relationships did not reach significance. Both abnormal plasma cobalt and chromium levels were associated with larger sizes of pseudotumor when present (p < 0.05).
CONCLUSIONS: In our sample, with a threshold of 5 ppb, abnormal plasma metal ions were associated with larger sizes of pseudotumors when present, but were not predictive of patient symptoms. Abnormal plasma cobalt levels have a significant association with periprosthetic lucency and presence of pseudotumor. Plasma chromium shows a similar pattern of association with lucency and presence of pseudotumor, although the relationships were not significant. Metal ion analysis should be used in conjunction with clinical and imaging evaluation and not as a sole indirect screening test when evaluating patients following metal-on-metal hip arthroplasty.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24257659     DOI: 10.2106/JBJS.L.01481

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  17 in total

1.  Early Lessons From a Worldwide, Multicenter, Followup Study of the Recalled Articular Surface Replacement Hip System.

Authors:  Rami Madanat; Daniel K Hussey; Gabrielle S Donahue; Hollis G Potter; Robert Wallace; Charles Bragdon; Orhun Muratoglu; Henrik Malchau
Journal:  Clin Orthop Relat Res       Date:  2015-08-27       Impact factor: 4.176

2.  Cemented metal-on-metal total hip replacement with 28-mm head: prospective, long-term, clinical, radiological and metal ions data.

Authors:  Ibrahim A Malek; Sheethal Prasad Patange Subba Rao; Narendra Kumar Rath; U N Mallya
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-12-19

3.  Heavy metal? Recognizing complications of metal on metal hip arthroplasty.

Authors:  Denise M Millstine; Hannah J Hakes; Anita P Mayer; Mark J Spangehl
Journal:  J Womens Health (Larchmt)       Date:  2014-06-16       Impact factor: 2.681

4.  What Is the Clinical Presentation of Adverse Local Tissue Reaction in Metal-on-metal Hip Arthroplasty? An MRI Study.

Authors:  Vincent P Galea; Inari Laaksonen; James W Connelly; Sean J Matuszak; Marc Nortje; Rami Madanat; Orhun Muratoglu; Henrik Malchau
Journal:  Clin Orthop Relat Res       Date:  2019-02       Impact factor: 4.176

5.  Ultrasound findings in asymptomatic patients with modular metal on metal total hip arthroplasty.

Authors:  Nicholas B Frisch; Nolan M Wessell; Kevin Taliaferro; Marnix Van Holsbeeck; Craig D Silverton
Journal:  Skeletal Radiol       Date:  2017-02-15       Impact factor: 2.199

6.  Influence of implant design on blood metal ion concentrations in metal-on-metal total hip replacement patients.

Authors:  Gulraj S Matharu; Fiona Berryman; Lesley Brash; Paul B Pynsent; Ronan B Treacy; David J Dunlop
Journal:  Int Orthop       Date:  2015-02-06       Impact factor: 3.075

7.  Do patients with a failed metal-on-metal hip implant with a pseudotumor present differences in their peripheral blood lymphocyte subpopulations?

Authors:  Isabelle Catelas; Eric A Lehoux; Ian Hurda; Stephen J Baskey; Luca Gala; Ryan Foster; Paul R Kim; Paul E Beaulé
Journal:  Clin Orthop Relat Res       Date:  2015-09-01       Impact factor: 4.176

Review 8.  Do retrieval analysis and blood metal measurements contribute to our understanding of adverse local tissue reactions?

Authors:  Patricia A Campbell; Michael S Kung; Andrew R Hsu; Joshua J Jacobs
Journal:  Clin Orthop Relat Res       Date:  2014-12       Impact factor: 4.176

9.  Mid- to long-term results of resurfacing hip arthroplasty in Japanese patients: a comparison of osteoarthritic vs non-osteoarthritic patients.

Authors:  Daisuke Inoue; Tamon Kabata; Yoshitomo Kajino; Tomoharu Takagi; Takaaki Ohmori; Junya Yoshitani; Takuro Ueno; Hiroyuki Tsuchiya
Journal:  J Artif Organs       Date:  2018-10-28       Impact factor: 1.731

10.  Hip resurfacing arthroplasty in treatment of avascular necrosis of the femoral head.

Authors:  Michał Pyda; Bogdan Koczy; Wojciech Widuchowski; Małgorzata Widuchowska; Tomasz Stołtny; Michał Mielnik; Jacek Hermanson
Journal:  Med Sci Monit       Date:  2015-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.